Skip to main content

Unum Group

For the period ended Jun 30, 2024. Filed Jul 31, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Jul 31, 2024

UNM$76.75+3.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Colonial Life Segment

The Colonial Life segment includes insurance for accident, sickness, and disability products, which includes dental and vision products, life products, and cancer and critical illness products. These products are marketed to employees, on both a group and an individual basis, at the workplace through an independent contractor agent sales force and brokers.

Shown below are financial results and key performance indicators for the Colonial Life segment.

(in millions of dollars, except ratios)
Three Months Ended June 30 · Six Months Ended June 30
2024 · % Change · 2023 · 2024 · % Change · 2023
Adjusted Operating Revenue
Premium Income
Accident, Sickness, and Disability$241.72.6%$235.6$484.92.9%$471.3
Life115.28.1106.6229.58.3211.9
Cancer and Critical Illness89.31.088.4178.71.0176.9
Total Premium Income446.23.6430.6893.13.8860.1
Net Investment Income40.56.638.079.86.075.3
Other Income0.2(50.0)0.43.2N.M0.6
Total486.93.8469.0976.14.3936.0
Benefits and Expenses
Policy Benefits222.91.2220.2449.61.9441.1
Policy Benefits - Remeasurement Gain(9.5)(22.1)(12.2)(19.1)N.M(5.4)
Commissions94.06.188.6189.26.4177.9
Deferral of Acquisition Costs(78.3)3.2(75.9)(157.6)4.3(151.1)
Amortization of Deferred Acquisition Costs54.312.248.4108.312.096.7
Other Expenses86.62.684.4175.14.6167.4
Total370.04.7353.5745.52.6726.6
Adjusted Operating Income$116.91.2$115.5$230.610.1$209.4
Operating Ratios (% of Premium Income):
Benefit Ratio47.8%48.3%48.2%50.7%
Other Expense Ratio19.4%19.6%19.6%19.5%
Adjusted Operating Income Ratio26.2%26.8%25.8%24.3%
Persistency:
Accident, Sickness, and Disability73.4%72.7%
Life84.8%84.2%
Cancer and Critical Illness82.0%82.0%
N.M. = not a meaningful percentage

Premium income in the second quarter and first six months of 2024 was favorable compared to the same periods of 2023 due to higher prior period sales and favorable persistency. Net investment income increased during the second quarter and first six months of 2024 relative to the same periods of 2023 due primarily to increases in the yield on invested assets and the level of invested assets.

The benefit ratio was favorable in the second quarter due to favorable benefit experience in the life and accident, sickness, and disability product lines. The benefit ratio was favorable in the first six months of 2024 compared to the same period of 2023 due to favorable benefit experience in the cancer and critical illness and accident, sickness, and disability product lines.

Commissions and the deferral of acquisition costs were higher in the second quarter and first six months of 2024 relative to the same periods of 2023 due to higher sales in prior periods. The amortization of deferred acquisition costs was higher during the second quarter and first six months of 2024 relative to the same periods of 2023 primarily due to growth in the level of the deferred asset. The other expense ratio was generally consistent in the second quarter and the first six months of 2024 relative to the same periods of 2023.

Sales

(in millions of dollars)
Three Months Ended June 30Six Months Ended June 30
2024% Change20232024% Change2023
Sales by Product
Accident, Sickness, and Disability$75.81.2%$74.9$140.4(0.7)%$141.4
Life29.8(1.3)30.254.6(3.2)56.4
Cancer and Critical Illness17.32.416.930.9(0.3)31.0
Total Sales$122.90.7$122.0$225.9(1.3)$228.8
Sales by Market Sector
Commercial
Core Market (< 1,000 employees)$78.8(2.7)%$81.0$150.5(2.5)%$154.4
Large Case Market12.13.411.721.3(2.3)21.8
Subtotal90.9(1.9)92.7171.8(2.5)176.2
Public Sector32.09.229.354.12.952.6
Total Sales$122.90.7$122.0$225.9(1.3)$228.8

Commercial market sales decreased in the second quarter and first six months of 2024 compared to the same periods of 2023 due primarily to lower sales to existing customers in the core market, which we define as accounts with less than 1,000 employees. Public sector market sales increased in the second quarter and first six months of 2024 compared to the same periods of 2023 due to higher sales to new customers.

We remain committed to providing employees and their families with simple, modern, and personal benefit solutions. During 2024, we will continue to utilize our strong distribution system of independent agents, benefit counselors and broker partnerships. We will also continue to invest in solutions and digital capabilities to expand our reach and effectiveness, driving growth and improving productivity while enhancing the customer experience. In 2024, we will continue to bring an enhanced engagement and enrollment platform to market, enabling deeper connections with employees through the enrollment process as well as maintaining stronger relationships throughout the customer lifecycle. We believe our distribution system, customer service capabilities, digital and virtual tools, and ability to serve all market sizes position us well for future growth.

In 2024, we expect strong growth in adjusted operating income for the full year with sales and premium growth increasing from the prior year. We expect improved claim experience in 2024 but could continue to experience some level of claims volatility. While we believe our underlying profitability will remain strong, current economic conditions and increasing competition in the voluntary workplace market are risks to achievement of our business plans. We continuously monitor key indicators to assess our risks and adjust our business plans accordingly.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.